img

Global Herpes Zoste Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Herpes Zoste Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Herpes Zoste Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Herpes Zoste Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Herpes Zoste Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Herpes Zoste Drug key manufacturers include Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc., Epiphany Biosciences, Inc., Foamix Pharmaceuticals Ltd., GeneOne Life Science, Inc., GlaxoSmithKline Plc, Merck & Co., Inc. and NAL Pharmaceuticals Ltd., etc. Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd, ContraVir Pharmaceuticals, Inc. are top 3 players and held % sales share in total in 2022.
Herpes Zoste Drug can be divided into Acyclovir, Amenamevir, FV-100 and GLS-5100, etc. Acyclovir is the mainstream product in the market, accounting for % sales share globally in 2022.
Herpes Zoste Drug is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Herpes Zoste Drug industry development. In 2022, global % sales of Herpes Zoste Drug went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Herpes Zoste Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Astellas Pharma Inc.
Beijing Minhai Biotechnology Co., Ltd
ContraVir Pharmaceuticals, Inc.
Epiphany Biosciences, Inc.
Foamix Pharmaceuticals Ltd.
GeneOne Life Science, Inc.
GlaxoSmithKline Plc
Merck & Co., Inc.
NAL Pharmaceuticals Ltd.
ReceptoPharm, Inc.
TSRL, Inc.
Segment by Type
Acyclovir
Amenamevir
FV-100
GLS-5100
GSK-1437173A
NAL-3221
Others

Segment by Application


Clinic
Hospital
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Herpes Zoste Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Herpes Zoste Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Herpes Zoste Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Herpes Zoste Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Herpes Zoste Drug introduction, etc. Herpes Zoste Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Herpes Zoste Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Herpes Zoste Drug Market Overview
1.1 Herpes Zoste Drug Product Overview
1.2 Herpes Zoste Drug Market Segment by Type
1.2.1 Acyclovir
1.2.2 Amenamevir
1.2.3 FV-100
1.2.4 GLS-5100
1.2.5 GSK-1437173A
1.2.6 NAL-3221
1.2.7 Others
1.3 Global Herpes Zoste Drug Market Size by Type
1.3.1 Global Herpes Zoste Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Herpes Zoste Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Herpes Zoste Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Herpes Zoste Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Herpes Zoste Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Herpes Zoste Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Herpes Zoste Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Herpes Zoste Drug Sales Breakdown by Type (2018-2024)
2 Global Herpes Zoste Drug Market Competition by Company
2.1 Global Top Players by Herpes Zoste Drug Sales (2018-2024)
2.2 Global Top Players by Herpes Zoste Drug Revenue (2018-2024)
2.3 Global Top Players by Herpes Zoste Drug Price (2018-2024)
2.4 Global Top Manufacturers Herpes Zoste Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Herpes Zoste Drug Market Competitive Situation and Trends
2.5.1 Herpes Zoste Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Herpes Zoste Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herpes Zoste Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Herpes Zoste Drug Market
2.8 Key Manufacturers Herpes Zoste Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Herpes Zoste Drug Status and Outlook by Region
3.1 Global Herpes Zoste Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Herpes Zoste Drug Historic Market Size by Region
3.2.1 Global Herpes Zoste Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Herpes Zoste Drug Sales in Value by Region (2018-2024)
3.2.3 Global Herpes Zoste Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Herpes Zoste Drug Forecasted Market Size by Region
3.3.1 Global Herpes Zoste Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Herpes Zoste Drug Sales in Value by Region (2024-2034)
3.3.3 Global Herpes Zoste Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Herpes Zoste Drug by Application
4.1 Herpes Zoste Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Herpes Zoste Drug Market Size by Application
4.2.1 Global Herpes Zoste Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Herpes Zoste Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Herpes Zoste Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Herpes Zoste Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Herpes Zoste Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Herpes Zoste Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Herpes Zoste Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Herpes Zoste Drug Sales Breakdown by Application (2018-2024)
5 North America Herpes Zoste Drug by Country
5.1 North America Herpes Zoste Drug Historic Market Size by Country
5.1.1 North America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Herpes Zoste Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Herpes Zoste Drug Sales in Value by Country (2018-2024)
5.2 North America Herpes Zoste Drug Forecasted Market Size by Country
5.2.1 North America Herpes Zoste Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Herpes Zoste Drug Sales in Value by Country (2024-2034)
6 Europe Herpes Zoste Drug by Country
6.1 Europe Herpes Zoste Drug Historic Market Size by Country
6.1.1 Europe Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Herpes Zoste Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Herpes Zoste Drug Sales in Value by Country (2018-2024)
6.2 Europe Herpes Zoste Drug Forecasted Market Size by Country
6.2.1 Europe Herpes Zoste Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Herpes Zoste Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Herpes Zoste Drug by Region
7.1 Asia-Pacific Herpes Zoste Drug Historic Market Size by Region
7.1.1 Asia-Pacific Herpes Zoste Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Herpes Zoste Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Herpes Zoste Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Herpes Zoste Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Herpes Zoste Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Herpes Zoste Drug Sales in Value by Region (2024-2034)
8 Latin America Herpes Zoste Drug by Country
8.1 Latin America Herpes Zoste Drug Historic Market Size by Country
8.1.1 Latin America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Herpes Zoste Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Herpes Zoste Drug Sales in Value by Country (2018-2024)
8.2 Latin America Herpes Zoste Drug Forecasted Market Size by Country
8.2.1 Latin America Herpes Zoste Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Herpes Zoste Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Herpes Zoste Drug by Country
9.1 Middle East and Africa Herpes Zoste Drug Historic Market Size by Country
9.1.1 Middle East and Africa Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Herpes Zoste Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Herpes Zoste Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Herpes Zoste Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Herpes Zoste Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Herpes Zoste Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Astellas Pharma Inc.
10.1.1 Astellas Pharma Inc. Company Information
10.1.2 Astellas Pharma Inc. Introduction and Business Overview
10.1.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Astellas Pharma Inc. Herpes Zoste Drug Products Offered
10.1.5 Astellas Pharma Inc. Recent Development
10.2 Beijing Minhai Biotechnology Co., Ltd
10.2.1 Beijing Minhai Biotechnology Co., Ltd Company Information
10.2.2 Beijing Minhai Biotechnology Co., Ltd Introduction and Business Overview
10.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Products Offered
10.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Development
10.3 ContraVir Pharmaceuticals, Inc.
10.3.1 ContraVir Pharmaceuticals, Inc. Company Information
10.3.2 ContraVir Pharmaceuticals, Inc. Introduction and Business Overview
10.3.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Products Offered
10.3.5 ContraVir Pharmaceuticals, Inc. Recent Development
10.4 Epiphany Biosciences, Inc.
10.4.1 Epiphany Biosciences, Inc. Company Information
10.4.2 Epiphany Biosciences, Inc. Introduction and Business Overview
10.4.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Products Offered
10.4.5 Epiphany Biosciences, Inc. Recent Development
10.5 Foamix Pharmaceuticals Ltd.
10.5.1 Foamix Pharmaceuticals Ltd. Company Information
10.5.2 Foamix Pharmaceuticals Ltd. Introduction and Business Overview
10.5.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
10.5.5 Foamix Pharmaceuticals Ltd. Recent Development
10.6 GeneOne Life Science, Inc.
10.6.1 GeneOne Life Science, Inc. Company Information
10.6.2 GeneOne Life Science, Inc. Introduction and Business Overview
10.6.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Products Offered
10.6.5 GeneOne Life Science, Inc. Recent Development
10.7 GlaxoSmithKline Plc
10.7.1 GlaxoSmithKline Plc Company Information
10.7.2 GlaxoSmithKline Plc Introduction and Business Overview
10.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Products Offered
10.7.5 GlaxoSmithKline Plc Recent Development
10.8 Merck & Co., Inc.
10.8.1 Merck & Co., Inc. Company Information
10.8.2 Merck & Co., Inc. Introduction and Business Overview
10.8.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Merck & Co., Inc. Herpes Zoste Drug Products Offered
10.8.5 Merck & Co., Inc. Recent Development
10.9 NAL Pharmaceuticals Ltd.
10.9.1 NAL Pharmaceuticals Ltd. Company Information
10.9.2 NAL Pharmaceuticals Ltd. Introduction and Business Overview
10.9.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
10.9.5 NAL Pharmaceuticals Ltd. Recent Development
10.10 ReceptoPharm, Inc.
10.10.1 ReceptoPharm, Inc. Company Information
10.10.2 ReceptoPharm, Inc. Introduction and Business Overview
10.10.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Products Offered
10.10.5 ReceptoPharm, Inc. Recent Development
10.11 TSRL, Inc.
10.11.1 TSRL, Inc. Company Information
10.11.2 TSRL, Inc. Introduction and Business Overview
10.11.3 TSRL, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 TSRL, Inc. Herpes Zoste Drug Products Offered
10.11.5 TSRL, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Herpes Zoste Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Herpes Zoste Drug Industrial Chain Analysis
11.4 Herpes Zoste Drug Market Dynamics
11.4.1 Herpes Zoste Drug Industry Trends
11.4.2 Herpes Zoste Drug Market Drivers
11.4.3 Herpes Zoste Drug Market Challenges
11.4.4 Herpes Zoste Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Herpes Zoste Drug Distributors
12.3 Herpes Zoste Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Acyclovir
Table 2. Major Company of Amenamevir
Table 3. Major Company of FV-100
Table 4. Major Company of GLS-5100
Table 5. Major Company of GSK-1437173A
Table 6. Major Company of NAL-3221
Table 7. Major Company of Others
Table 8. Global Herpes Zoste Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Herpes Zoste Drug Sales by Type (2018-2024) & (K Pcs)
Table 10. Global Herpes Zoste Drug Sales Market Share in Volume by Type (2018-2024)
Table 11. Global Herpes Zoste Drug Sales by Type (2018-2024) & (US& Million)
Table 12. Global Herpes Zoste Drug Market Share in Value by Type (2018-2024)
Table 13. Global Herpes Zoste Drug Price by Type (2018-2024) & (USD/Pcs)
Table 14. Global Herpes Zoste Drug Sales by Type (2024-2034) & (K Pcs)
Table 15. Global Herpes Zoste Drug Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Herpes Zoste Drug Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Herpes Zoste Drug Sales Market Share in Value by Type (2024-2034)
Table 18. Global Herpes Zoste Drug Price by Type (2024-2034) & (USD/Pcs)
Table 19. North America Herpes Zoste Drug Sales by Type (2018-2024) & (K Pcs)
Table 20. North America Herpes Zoste Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Europe Herpes Zoste Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Europe Herpes Zoste Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Asia-Pacific Herpes Zoste Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Asia-Pacific Herpes Zoste Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Latin America Herpes Zoste Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Latin America Herpes Zoste Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Middle East and Africa Herpes Zoste Drug Sales (K Pcs) by Type (2018-2024)
Table 28. Middle East and Africa Herpes Zoste Drug Sales by Type (2018-2024) & (US$ Million)
Table 29. Global Herpes Zoste Drug Sales by Company (2018-2024) & (K Pcs)
Table 30. Global Herpes Zoste Drug Sales Share by Company (2018-2024)
Table 31. Global Herpes Zoste Drug Revenue by Company (2018-2024) & (US$ Million)
Table 32. Global Herpes Zoste Drug Revenue Share by Company (2018-2024)
Table 33. Global Market Herpes Zoste Drug Price by Company (2018-2024) & (USD/Pcs)
Table 34. Global Herpes Zoste Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Herpes Zoste Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herpes Zoste Drug as of 2022)
Table 37. Date of Key Manufacturers Enter into Herpes Zoste Drug Market
Table 38. Key Manufacturers Herpes Zoste Drug Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Herpes Zoste Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 41. Global Herpes Zoste Drug Sales by Region (2018-2024) & (K Pcs)
Table 42. Global Herpes Zoste Drug Sales Market Share in Volume by Region (2018-2024)
Table 43. Global Herpes Zoste Drug Sales by Region (2018-2024) & (US$ Million)
Table 44. Global Herpes Zoste Drug Sales Market Share in Value by Region (2018-2024)
Table 45. Global Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 46. Global Herpes Zoste Drug Sales by Region (2024-2034) & (K Pcs)
Table 47. Global Herpes Zoste Drug Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Herpes Zoste Drug Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Herpes Zoste Drug Sales Market Share in Value by Region (2024-2034)
Table 50. Global Herpes Zoste Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 51. Global Herpes Zoste Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 52. Global Herpes Zoste Drug Sales by Application (2018-2024) & (K Pcs)
Table 53. Global Herpes Zoste Drug Sales Market Share in Volume by Application (2018-2024)
Table 54. Global Herpes Zoste Drug Sales by Application (2018-2024) & (US$ Million)
Table 55. Global Herpes Zoste Drug Sales Market Share in Value by Application (2018-2024)
Table 56. Global Herpes Zoste Drug Price by Application (2018-2024) & (USD/Pcs)
Table 57. Global Herpes Zoste Drug Sales by Application (2024-2034) & (K Pcs)
Table 58. Global Herpes Zoste Drug Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Herpes Zoste Drug Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Herpes Zoste Drug Sales Market Share in Value by Application (2024-2034)
Table 61. Global Herpes Zoste Drug Price by Application (2024-2034) & (USD/Pcs)
Table 62. North America Herpes Zoste Drug Sales by Application (2018-2024) (K Pcs)
Table 63. North America Herpes Zoste Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Europe Herpes Zoste Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Europe Herpes Zoste Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Asia-Pacific Herpes Zoste Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Asia-Pacific Herpes Zoste Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Latin America Herpes Zoste Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Latin America Herpes Zoste Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Herpes Zoste Drug Sales by Application (2018-2024) (K Pcs)
Table 71. Middle East and Africa Herpes Zoste Drug Sales by Application (2018-2024) & (US$ Million)
Table 72. North America Herpes Zoste Drug Sales by Country (2018-2024) & (K Pcs)
Table 73. North America Herpes Zoste Drug Sales Market Share in Volume by Country (2018-2024)
Table 74. North America Herpes Zoste Drug Sales by Country (2018-2024) & (US$ Million)
Table 75. North America Herpes Zoste Drug Sales Market Share in Value by Country (2018-2024)
Table 76. North America Herpes Zoste Drug Sales by Country (2024-2034) & (K Pcs)
Table 77. North America Herpes Zoste Drug Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Herpes Zoste Drug Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Herpes Zoste Drug Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Herpes Zoste Drug Sales by Country (2018-2024) & (K Pcs)
Table 81. Europe Herpes Zoste Drug Sales Market Share in Volume by Country (2018-2024)
Table 82. Europe Herpes Zoste Drug Sales by Country (2018-2024) & (US$ Million)
Table 83. Europe Herpes Zoste Drug Sales Market Share in Value by Country (2018-2024)
Table 84. Europe Herpes Zoste Drug Sales by Country (2024-2034) & (K Pcs)
Table 85. Europe Herpes Zoste Drug Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Herpes Zoste Drug Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Herpes Zoste Drug Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Herpes Zoste Drug Sales by Region (2018-2024) & (K Pcs)
Table 89. Asia-Pacific Herpes Zoste Drug Sales Market Share in Volume by Region (2018-2024)
Table 90. Asia-Pacific Herpes Zoste Drug Sales by Region (2018-2024) & (US$ Million)
Table 91. Asia-Pacific Herpes Zoste Drug Sales Market Share in Value by Region (2018-2024)
Table 92. Asia-Pacific Herpes Zoste Drug Sales by Region (2024-2034) & (K Pcs)
Table 93. Asia-Pacific Herpes Zoste Drug Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Herpes Zoste Drug Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Herpes Zoste Drug Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Herpes Zoste Drug Sales by Country (2018-2024) & (K Pcs)
Table 97. Latin America Herpes Zoste Drug Sales Market Share in Volume by Country (2018-2024)
Table 98. Latin America Herpes Zoste Drug Sales by Country (2018-2024) & (US$ Million)
Table 99. Latin America Herpes Zoste Drug Sales Market Share in Value by Country (2018-2024)
Table 100. Latin America Herpes Zoste Drug Sales by Country (2024-2034) & (K Pcs)
Table 101. Latin America Herpes Zoste Drug Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Herpes Zoste Drug Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Herpes Zoste Drug Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Herpes Zoste Drug Sales by Country (2018-2024) & (K Pcs)
Table 105. Middle East and Africa Herpes Zoste Drug Sales Market Share in Volume by Country (2018-2024)
Table 106. Middle East and Africa Herpes Zoste Drug Sales by Country (2018-2024) & (US$ Million)
Table 107. Middle East and Africa Herpes Zoste Drug Sales Market Share in Value by Country (2018-2024)
Table 108. Middle East and Africa Herpes Zoste Drug Sales by Country (2024-2034) & (K Pcs)
Table 109. Middle East and Africa Herpes Zoste Drug Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Herpes Zoste Drug Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Herpes Zoste Drug Sales Market Share in Value by Country (2024-2034)
Table 112. Astellas Pharma Inc. Company Information
Table 113. Astellas Pharma Inc. Introduction and Business Overview
Table 114. Astellas Pharma Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Astellas Pharma Inc. Herpes Zoste Drug Product
Table 116. Astellas Pharma Inc. Recent Development
Table 117. Beijing Minhai Biotechnology Co., Ltd Company Information
Table 118. Beijing Minhai Biotechnology Co., Ltd Introduction and Business Overview
Table 119. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product
Table 121. Beijing Minhai Biotechnology Co., Ltd Recent Development
Table 122. ContraVir Pharmaceuticals, Inc. Company Information
Table 123. ContraVir Pharmaceuticals, Inc. Introduction and Business Overview
Table 124. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product
Table 126. ContraVir Pharmaceuticals, Inc. Recent Development
Table 127. Epiphany Biosciences, Inc. Company Information
Table 128. Epiphany Biosciences, Inc. Introduction and Business Overview
Table 129. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Epiphany Biosciences, Inc. Herpes Zoste Drug Product
Table 131. Epiphany Biosciences, Inc. Recent Development
Table 132. Foamix Pharmaceuticals Ltd. Company Information
Table 133. Foamix Pharmaceuticals Ltd. Introduction and Business Overview
Table 134. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product
Table 136. Foamix Pharmaceuticals Ltd. Recent Development
Table 137. GeneOne Life Science, Inc. Company Information
Table 138. GeneOne Life Science, Inc. Introduction and Business Overview
Table 139. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. GeneOne Life Science, Inc. Herpes Zoste Drug Product
Table 141. GeneOne Life Science, Inc. Recent Development
Table 142. GlaxoSmithKline Plc Company Information
Table 143. GlaxoSmithKline Plc Introduction and Business Overview
Table 144. GlaxoSmithKline Plc Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. GlaxoSmithKline Plc Herpes Zoste Drug Product
Table 146. GlaxoSmithKline Plc Recent Development
Table 147. Merck & Co., Inc. Company Information
Table 148. Merck & Co., Inc. Introduction and Business Overview
Table 149. Merck & Co., Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Merck & Co., Inc. Herpes Zoste Drug Product
Table 151. Merck & Co., Inc. Recent Development
Table 152. NAL Pharmaceuticals Ltd. Company Information
Table 153. NAL Pharmaceuticals Ltd. Introduction and Business Overview
Table 154. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product
Table 156. NAL Pharmaceuticals Ltd. Recent Development
Table 157. ReceptoPharm, Inc. Company Information
Table 158. ReceptoPharm, Inc. Introduction and Business Overview
Table 159. ReceptoPharm, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. ReceptoPharm, Inc. Herpes Zoste Drug Product
Table 161. ReceptoPharm, Inc. Recent Development
Table 162. TSRL, Inc. Company Information
Table 163. TSRL, Inc. Introduction and Business Overview
Table 164. TSRL, Inc. Herpes Zoste Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. TSRL, Inc. Herpes Zoste Drug Product
Table 166. TSRL, Inc. Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Herpes Zoste Drug Market Trends
Table 170. Herpes Zoste Drug Market Drivers
Table 171. Herpes Zoste Drug Market Challenges
Table 172. Herpes Zoste Drug Market Restraints
Table 173. Herpes Zoste Drug Distributors List
Table 174. Herpes Zoste Drug Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Zoste Drug Product Picture
Figure 2. Global Herpes Zoste Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Herpes Zoste Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Herpes Zoste Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Acyclovir
Figure 6. Global Acyclovir Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Amenamevir
Figure 8. Global Amenamevir Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of FV-100
Figure 10. Global FV-100 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of GLS-5100
Figure 12. Global GLS-5100 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of GSK-1437173A
Figure 14. Global GSK-1437173A Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of NAL-3221
Figure 16. Global NAL-3221 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 19. Global Herpes Zoste Drug Sales by Type (2018-2034) & (US$ Million)
Figure 20. Global Herpes Zoste Drug Sales Market Share by Type in 2022 & 2034
Figure 21. North America Herpes Zoste Drug Sales Market Share in Volume by Type in 2022
Figure 22. North America Herpes Zoste Drug Sales Market Share in Value by Type in 2022
Figure 23. Europe Herpes Zoste Drug Sales Market Share in Volume by Type in 2022
Figure 24. Europe Herpes Zoste Drug Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Herpes Zoste Drug Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Herpes Zoste Drug Sales Market Share in Value by Type in 2022
Figure 27. Latin America Herpes Zoste Drug Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Herpes Zoste Drug Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Herpes Zoste Drug Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Herpes Zoste Drug Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Herpes Zoste Drug Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Herpes Zoste Drug Revenue in 2022
Figure 33. Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Hospital
Figure 37. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global Herpes Zoste Drug Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Herpes Zoste Drug Sales Market Share by Application in 2022 & 2034
Figure 42. North America Herpes Zoste Drug Sales Market Share in Volume by Application in 2022
Figure 43. North America Herpes Zoste Drug Sales Market Share in Value by Application in 2022
Figure 44. Europe Herpes Zoste Drug Sales Market Share in Volume by Application in 2022
Figure 45. Europe Herpes Zoste Drug Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Herpes Zoste Drug Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Herpes Zoste Drug Sales Market Share in Value by Application in 2022
Figure 48. Latin America Herpes Zoste Drug Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Herpes Zoste Drug Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Herpes Zoste Drug Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Herpes Zoste Drug Manufacturing Cost Structure
Figure 53. Herpes Zoste Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries